NCT04938076Completed
Efficacy of Transcranial Direct Current Stimulation in Acute Ischemic Stroke
Investigation of the Effects of Noninvasive Neuromodulation in Patients With Acute Ischemic Infarction
Source: ClinicalTrials.gov · Last updated 24 Jul 2024
Brief summary (registry, in English)
Non-invasive brain stimulation (tDCS) such as transcranial direct current stimulation (TDCS) has been reported to be effective in improving motor performance and safe in participants with cerebral infarction. However, few studies have been done in participants with acute cerebral infarction. In this study, the investigators want to see the effect of tDCS in acute cerebral infarction. the investigators perform tDCS in participants with acute ischemic stroke within 48 hours after stroke onset and the investigators measure motor weakness and function at early phase as well as at 3 months.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 172 (actual)
- First submitted
- 15 Jun 2021
- Start date
- 16 Apr 2020
- Primary completion date
- 1 Feb 2024
- Lead sponsor
- Incheon St.Mary's Hospital
- Diseases
- Stroke
- NCT number
- NCT04938076
What you commit to
- Study type: Interventional
- Participants enrolled: 172
- From 16 Apr 2020 to the primary completion date, 1 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- pre-stroke disability (defined as modified Rankin Scale (mRS) \>=2)
- history of epilepsy
- advanced systemic disease or coexisting neurological/psychiatric disease
Other
- Intravenous r-tPA thrombolysis or EVT (endovascular thrombectomy)
- severe contact dermatitis or skin lesions interfering with the applying the electrode of tDCS
Who the study is looking for
- ischemic stroke patients within 2 days stroke onset
- 18-85 of age
- corticospinal tract involvement stroke (primary motor cortex, corona radiata, internal capsule, midbrain crus cerebri, basis pontis, anterior medulla)
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Catholic University of Korea, Incheon St. Mary's Hospital Coordinator of this site? Confirm its status | Incheon | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.